Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice

被引：0
|
作者：
Tong Li
Jiandong Wang
机构：
[1] Beijing Obstetrics and Gynecology Hospital,Department of Gynecologic Oncology
[2] Capital Medical University,undefined
来源：
BMC Cancer | / 20卷
关键词：
Chimeric antigen receptor T cell; Mucin 16; Programmed cell death-ligand 1; Ovarian cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice
    Li, Tong
    Wang, Jiandong
    BMC CANCER, 2020, 20 (01)
  • [2] Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
    Mun, Sung Soo
    Meyerberg, Jeremy
    Peraro, Leila
    Korontsvit, Tatyana
    Gardner, Thomas
    Malviya, Manish
    Kyi, Chrisann
    O'Cearbhaill, Roisin E.
    Liu, Cheng
    Dao, Tao
    Scheinberg, David A.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (11) : 3773 - 3786
  • [3] Dual targeting ovarian cancer by Muc16 CAR T cells secreting a bispecific T cell engager antibody for an intracellular tumor antigen WT1
    Sung Soo Mun
    Jeremy Meyerberg
    Leila Peraro
    Tatyana Korontsvit
    Thomas Gardner
    Manish Malviya
    Chrisann Kyi
    Roisin E. O’Cearbhaill
    Cheng Liu
    Tao Dao
    David A. Scheinberg
    Cancer Immunology, Immunotherapy, 2023, 72 : 3773 - 3786
  • [4] Novel mesothelin-based CAR T cells targeting MUC16 as an intravesical bladder cancer therapy
    Abrahimi, Parwiz
    Khan, Jonathan
    Brentjens, Renier
    Merghoub, Taha
    Wolchok, Jedd
    CLINICAL CANCER RESEARCH, 2024, 30 (10)
  • [5] INTRAVESICAL MUC16 TARGETING CAR T CELLS FOR ORGAN-CONFINED BLADDER CANCERS
    Parwiz, Abrahimi
    Jonathan, Khan
    Alyssa, Duren-Lubanski
    Winson, Cai
    Yacine, Marouf
    Jacob, Tallman
    Bishoy, Faltas
    Hikmat, Al Ahmadie
    Olivier, Elemento
    Benjamin, Hopkins
    Douglas, Scherr
    Renier, Brentjens
    Jedd, Wolchok
    Taha, Merghoub
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03)
  • [6] Enhancing the antitumor effect of MUC16 CART cells in ovarian cancer: The potential of oncolytic adenovirus
    Wang, Qiuman
    Liu, Wanchuan
    Fan, Yuanchun
    Liu, Shihao
    Li, Rongrong
    Yan, Shi
    Song, Kun
    Zhang, Hui
    Yuan, Cunzhong
    CANCER LETTERS, 2025, 616
  • [7] EPIDEMIOLOGIC AND MEDICAL FACTORS ASSOCIATED WITH ANTIBODIES AGAINST TUMOR ASSOCIATED ANTIGENS MUC1 AND MUC16: POSSIBLE RELEVANCE TO OVARIAN CANCER
    Williams, Kristina
    Vitonis, Allison
    Yamamoto, Hidemi
    Fichorova, Raina N.
    Cramer, Daniel
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 177 : S89 - S89
  • [8] Tandem CAR-T cells targeting FOLR1 and MSLN enhance the antitumor effects in ovarian cancer
    Liang, Zhen
    Dong, Jiao
    Yang, Neng
    Li, Si-Di
    Yang, Ze-Yu
    Huang, Rui
    Li, Feng-Jie
    Wang, Wen-Ting
    Ren, Jia-Kui
    Lei, Jie
    Xu, Chen
    Wang, Dan
    Wang, Yan-Zhou
    Liang, Zhi-Qing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (15): : 4365 - 4376
  • [9] ROR1-targeting switchable CAR-T cells for cancer therapy
    Haiyong Peng
    Thomas Nerreter
    Katrin Mestermann
    Jakob Wachter
    Jing Chang
    Michael Hudecek
    Christoph Rader
    Oncogene, 2022, 41 : 4104 - 4114
  • [10] ROR1-targeting switchable CAR-T cells for cancer therapy
    Peng, Haiyong
    Nerreter, Thomas
    Mestermann, Katrin
    Wachter, Jakob
    Chang, Jing
    Hudecek, Michael
    Rader, Christoph
    ONCOGENE, 2022,
12345